Duvortuxizumab
Duvortuxizumab is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Janssen Pharmaceutica.
Mechanism of Action[edit]
Duvortuxizumab is a monoclonal antibody that targets the CD19 antigen, a protein expressed on the surface of B-cell lymphomas and leukemias. By binding to this antigen, duvortuxizumab can direct the body's immune system to destroy the cancer cells.
Clinical Trials[edit]
Duvortuxizumab has been tested in clinical trials for the treatment of Non-Hodgkin lymphoma and Acute lymphoblastic leukemia. The results of these trials have shown promise, but further research is needed to determine the drug's efficacy and safety profile.
Side Effects[edit]
Like all drugs, duvortuxizumab can cause side effects. The most common side effects reported in clinical trials include fever, fatigue, and nausea. More serious side effects can include infection, anemia, and neutropenia.
See Also[edit]
References[edit]
<references />
 | This medical article is a stub. You can help WikiMD by expanding the page. |
| This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
